Launch strategy·
US-first isn't a strategy. It's a habit. And the conditions that made the habit safe no longer hold.
Why the choice of first market sets the price chain for the life of the asset.
Notes from the princıpals.
Short pieces on market sequencing, launch strategy, and access. Written for CEOs, CSOs, and heads of strategy preparing to launch across more than one region.
Launch strategy·
Rethinking China's role in biotech launch sequences: what most teams get wrong
China can accelerate biotech development faster than any other market — but its pricing structure means it cannot be your value-capture market. How to position it in your sequence, and the four questions to answer before you do.